x
Filter:
Filters applied
- Coronavirus (COVID-19) Collection
- Almalki, SafarRemove Almalki, Safar filter
- SeroprevalenceRemove Seroprevalence filter
- 2020 - 2022Remove 2020 - 2022 filter
Author
- Abuhaimed, Yousef1
- Al-Qunaibet, Ada1
- Al-Tawfiq, Jaffar A1
- Alabdulkareem, Khaled1
- Alaswad, Rehab1
- Alfaifi, Amal1
- AlJurayyan, Abdullah1
- Alkhashan, Abdullah1
- Almolad, Shaza Karim1
- Almudaiheem, Abdullah1
- Almudarra, Sami1
- Almutlaq, Hind1
- Alotaibi, Abdullah1
- Alqahtani, Saeed1
- Alruwaily, Amaal1
- Alsaif, Faisal1
- Alserehi, Haleema1
- Assiri, Abdullah1
- Banjar, Ayman1
- Jokhdar, Hani1
- Khojah, Abdullah T1
Coronavirus (COVID-19) Collection
1 Results
- Research ArticleOpen Access
Seroprevalence of antibodies to SARS-CoV-2 among blood donors in the early months of the pandemic in Saudi Arabia
International Journal of Infectious DiseasesVol. 104p452–457Published online: January 16, 2021- Ayman Banjar
- Jaffar A. Al-Tawfiq
- Amaal Alruwaily
- Haleema Alserehi
- Ada Al-Qunaibet
- Rehab Alaswad
- and others
Cited in Scopus: 21Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a novel coronavirus causing Coronavirus Disease-19 (COVID-19) infection at a pandemic scale. It was first detected in Wuhan city, China, in December 2019 and has since rapidly spread worldwide including the Kingdom of Saudi Arabia (AlJishi and Al-Tawfiq, 2021; AlJishi et al., 2021; Al-Tawfiq and Memish, 2020b). Patients with COVID-19 have a wide clinical spectrum from an asymptomatic or mild infection in most cases to a severe acute respiratory syndrome (SARS) in others (Al-Tawfiq, 2020).
